RECRUITING

The Aim of This Study is to Determine if Oocyte Sorting for Group Culture Using an Artificial Intelligence Image Analysis Tool (MagentaTM) Increases the Usable Blastocyst Yield and Subsequent Pregnancy in Patients Undergoing IVF

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The aim of this study is to determine if oocyte sorting for group culture using an artificial intelligence image analysis tool (MagentaTM) increases the usable blastocyst yield and subsequent pregnancy in patients undergoing IVF.

Official Title

NiOS (Non-Invasive Oocyte Sorting) Study

Quick Facts

Study Start:2024-01-01
Study Completion:2027-01-02
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06521372

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Fresh MII oocytes
  2. * ICSI cycles with patient's or donor's sperm
  3. * Patient's or donor's oocytes
  4. * Full IVF cycle information available (including total number of oocytes retrieved, total MII oocytes, fertilization, embryo and blastocyst development, as well as ploidy status or implantation results, and 6-7 week ultrasound, if applicable)
  5. * Good quality images of MII oocytes taken with a specified camera (Basler) and Future Fertility Software
  6. * Single embryo transfers (SETs) at blastocyst stage.
  7. * Blastocyst freeze-all cycles
  1. * Severe male factor infertility (\<1 million motile), including surgically retrieved sperm.
  2. * ICSI cycles inseminating in vitro matured (IVM) oocytes
  3. * Rescue ICSI oocytes (oocytes failed standard IVF and are re-inseminated by ICSI)
  4. * Low quality images - Poor quality images on day of upload or before unblinding
  5. * Lack of correlating reproductive outcomes (full IVF lab results not available).
  6. * Autologous or donor frozen/warmed oocytes
  7. * Day 3 embryo transfers or cleavage stage embryo freezing
  8. * Patients with less than 6 mature oocytes

Contacts and Locations

Study Locations (Sites)

Ovation Fertility Las Vegas
Las Vegas, Nevada, 89113
United States
Ovation Fertility Cincinnati
Cincinnati, Ohio, 45209
United States
Ovation Fertility - Nashville
Nashville, Tennessee, 37203
United States

Collaborators and Investigators

Sponsor: Ovation Fertility

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-01-01
Study Completion Date2027-01-02

Study Record Updates

Study Start Date2024-01-01
Study Completion Date2027-01-02

Terms related to this study

Keywords Provided by Researchers

  • Artificial Intelligence

Additional Relevant MeSH Terms

  • Infertility Primary